S'abonner

Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005–2013: A single center study - 22/11/17

Doi : 10.1016/j.jclinane.2017.09.005 
Allan W. Belcher, MD a, 1, Steve Leung, MD b, 1, Barak Cohen, MD b, Dongsheng Yang, MS c, Edward J. Mascha, PhD c, Alparslan Turan, MD b, d, Leif Saager, Dr. med., MMM e, f, Kurt Ruetzler, MD b, d,
a Department of Internal Medicine, Medicine Institute, Cleveland Clinic, Cleveland, OH, United States 
b Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States 
c Department of Quantitative Health Sciences, Cleveland Clinic, OH, United States 
d Department of General Anesthesiology, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States 
e Outcomes Research Consortium, Cleveland, OH, United States 
f University of Michigan, Department of Anesthesiology, University of Michigan, Ann Arbor, MI, United States 

Corresponding author at: Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, 9500 Euclid Avenue, P-77, Cleveland, OH 44195, United States.Department of Outcomes ResearchAnesthesiology InstituteCleveland Clinic9500 Euclid Avenue, P-77ClevelandOH44195United States

Abstract

Study objective

The use of neuromuscular blockade agents (NMBA), had been associated with significant residual post-operative paralysis and morbidity. There is a lack of clinical evidence on incidence of postoperative complications within the post-anesthesia care unit (PACU) in patients exposed to intraoperative NMBA's. This study aims to estimate the incidence of post-operative complications associated with use of NMBAs and assessing its association with healthcare resource utilization.

Design

Retrospective cohort.

Setting

Post-anesthesia care unit in tertiary care center.

Patients

Adults having non-cardiac surgery and receiving NMBAs between April-2005 and December-2013

Measurements

We assessed: 1) incidences of major and minor PACU complications, 2) incidence of any postoperative complication in patients receiving a NMBA reversal (neostigmine) vs. without. 3) We secondarily assessed the relationship between PACU complications and use of healthcare resources.

Main results

The incidence of any major complications was 2.1% and that of any minor complication was 35.2%. ICU admission rate was 1.3% in patients without any complications, versus 5.2% in patients with any minor and 30.6% in patients with any major complication. ICU length of stay was prolonged in patients with any major (52.1±203h), compared to patients with any minor (6.2±64h) and with no complications (1.7±28h). Patients who received a NMBA and neostigmine, compared to without neostigmine, had a lower incidence of any major complication (1.7% vs. 6.05%), rate of re-intubation (0.8% vs. 4.6%) and unplanned ICU admission (0.8% vs. 3.2%).

Conclusions

This study documents that incidence of major PACU complications after non-cardiac surgery was 2.1%, with the most frequent complications being re-intubation and ICU admission. Patients receiving NMBA reversal were at a lower risk of re-intubation and unplanned ICU admission, justifying routine use of reversals. Complete NMBA reversals are crucial in reducing preventable patient harm and healthcare utilization.

Le texte complet de cet article est disponible en PDF.

Highlights

Incidence of major (2.1%) and minor (35.1%) complications in the PACU are common in patients having surgery
ICU admission rate was 1.3% without any complications, 3% with any minor, and 54% with any major complication
In-hospital mortality was 0.2% without any complication, 0.4% with any minor, and 3% with any major complication
Reversal of muscle relaxants significantly reduces risk of any major complication (1.7% vs. 6.0)

Le texte complet de cet article est disponible en PDF.

Keywords : Neuromuscular blockade, Postoperative complications, PACU


Plan


 Received from the Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States.


© 2017  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 43

P. 33-38 - décembre 2017 Retour au numéro
Article précédent Article précédent
  • Medicaid insurance as primary payer predicts increased mortality after total hip replacement in the state inpatient databases of California, Florida and New York
  • Hannah F. Xu, Robert S. White, Dahniel L. Sastow, Michael H. Andreae, Licia K. Gaber-Baylis, Zachary A. Turnbull
| Article suivant Article suivant
  • Postpartum tubal ligation: A retrospective review of anesthetic management at a single institution and a practice survey of academic institutions
  • Christine McKenzie, Seden Akdagli, Gillian Abir, Brendan Carvalho

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.